MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuropsychiatric non-motor manifestations in patients with focal dystonia

H.W Shin (Seoul, Republic of Korea)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1178

Keywords: Dystonia: Clinical features

Category: Phenomenology and Clinical Assessment of Movement Disorders

Objective: We aimed to evaluate the neuro-psychiatric manifestations in focal dystonia patients.

Background: Idiopathic focal dystonia is one of the most common forms of dystonia observed in adults. This condition may be associated with a number of neural substrates such as the basal ganglia, cerebellum, motor, and associative motor areas; therefore, recent studies suggest that dystonia may be classified as a neural network disorder. It is possible that focal dystonia in patients may present through various non-motor manifestations such as, sensory, cognitive, and neuropsychiatric.

Method: In this prospective, case-control, cross-sectional study, we recruited 27 patients with focal dystonia, 24 patients with essential tremor for disease control participants, and 23 healthy control participants of similar ages. We examined them using the Burke-Fahn-Marsden (BFM) Dystonia Rating Scale. The participants were subsequently tasked with completing the following set of questionnaires: Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), K-Mini Mental Status Examination (K-MMSE), Mini international neuropsychiatry interview (M.I.N.I.), and Maudsley Obsessive Compulsive Inventory.

Results: The K-MMSE data were studied and compared among the predetermined groups. Mean BFM dystonia rating scale was 7.04±6.51. Patients with focal dystonia and ET had higher scores in BAI (8.79±8.12, 8.33±6.60, and 3.80±4.40 in dystonia, ET, and control, respectively, p=0.0161) and BDI (9.71±6.85, 9.25±7.40, and 3.85±4.96 in dystonia, ET, and control, respectively, p=0.0015) than did the healthy controls. The dystonia and ET groups did not present any significant differences among each other for these scores (p>0.05). Frequency of subjects with psychiatric disorders was comparable among the groups (p=0.1632); however, dystonia patients presented with higher frequencies of psychiatric disorders (48%, 33%, and 17% in dystonia, ET, and controls, respectively).

Conclusion: Dystonia patients demonstrated a higher number of symptoms associated with depression and anxiety than did the healthy controls. However, these symptoms were similar to those observed in the disease controls, suggesting that depression and anxiety in focal dystonia patients may not be disease specific. Although not statistically significant, participants in the dystonia group demonstrated a higher frequency of psychiatric disorders.

To cite this abstract in AMA style:

H.W Shin. Neuropsychiatric non-motor manifestations in patients with focal dystonia [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/neuropsychiatric-non-motor-manifestations-in-patients-with-focal-dystonia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuropsychiatric-non-motor-manifestations-in-patients-with-focal-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley